Novogen (NVGN)

4.00 -0.04  -0.99%  May 20, 3:22PM
Add to Watchlists Create an Alert

Novogen Debt to Equity Ratio

View Full Chart

Novogen Debt to Equity Ratio Chart

    Novogen Historical Debt to Equity Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    June 30, 2012 0.00
    June 30, 2011 0.00
    June 30, 2010 0.00
    June 30, 2009 0.00
    June 30, 2008 0.00
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
       
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro

    About Debt to Equity Ratio

    Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

    A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

    It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
    Learn More

    Get data for

    NVGN Debt to Equity Ratio Benchmarks

    Companies
    GlaxoSmithKline 2.886
    Tetraphase Pharmaceuticals
    Zoetis 0.1446

    NVGN Debt to Equity Ratio Range, Past 5 Years

    Minimum 0.00 Jun 2008
    Maximum 0.00 Jun 2008
    Average 0.00